Home > Effectiveness Bank Bulletin. [Prison health care].

Drug and Alcohol Findings. (2013) Effectiveness Bank Bulletin. [Prison health care]. London: Drug and Alcohol Findings. Effectiveness Bank Bulletin, 11 Jun

[img]
Preview
PDF (1. The effectiveness of Prisoners Addressing Substance Related Offending (P-ASRO) programme)
70kB
[img]
Preview
PDF (2. Comparison of methadone and buprenorphine for opiate detoxification (LEEDS trial))
56kB
[img]
Preview
PDF (3. The effectiveness of opioid maintenance treatment in prison settings)
69kB

URL: http://findings.org.uk/docs/bulletins/Bull_11_06_1...

1. The effectiveness of Prisoners Addressing Substance Related Offending (P-ASRO) programme: evaluating the pre and post treatment psychometric outcomes in an adult male category C prison.
Crane M.A.J., Blud L. British Journal of Forensic Practice: 2012, 14(1), p.49–59.
From the early 2000s cognitive-behavioural group therapy programmes have been relied on to improve the anti-offending record of UK prisons and probation services, but evidence has been scarce and generally negative. This prison study at least suggests that one such programme does promote the intended psychological changes.

2. Comparison of methadone and buprenorphine for opiate detoxification (LEEDS trial): a randomised controlled trial.
Wright N.M.J., Sheard L., Adams C.E. et al. British Journal of General Practice: December 2011.
Three English prisons hosted the first randomised trial of tapering doses of buprenorphine versus methadone to ease the withdrawal of opiate users entering prison. As outside prison, there was little difference in their effectiveness, and three months later just a fifth of the (former) prisoners were assessed as no longer using illegal opiates.

3. The effectiveness of opioid maintenance treatment in prison settings: a systematic review.
Hedrich D., Alves P., Farrell M. et al. Addiction: 2012, 107(3), p. 501–517.
Largely due to the treatment's health benefits, this review argues that failure to implement effective opioid maintenance programmes in prison represents an important missed opportunity to engage high-risk drug users in treatment, at possibly substantial costs both to individuals and to the community.


Item Type:Evidence resource
Publication Type:Review
Drug Type:Alcohol or other drugs in general, Opioid
Intervention Type:AOD disorder treatment method, AOD disorder drug therapy, AOD disorder harm reduction, Psychosocial treatment method
Source:Drug and Alcohol Findings
Date:11 June 2013
Publisher:Drug and Alcohol Findings
Corporate Creators:Drug and Alcohol Findings
Place of Publication:London
Volume:11 Jun
EndNote:View
Accession Number:HRB (Electronic Only)
Subjects:B Substances > Opioids (opiates)
B Substances > Opioids (opiates) > Opioid product > Buprenorphine / Suboxone
HJ Treatment method > Substance disorder treatment method > Substance replacement method (substitution) > Methadone maintenance
HJ Treatment method > Directive and nondirective therapy > Psychoanalytic therapy > Cognitive behavioural therapy (CBT)
J Health care, prevention and rehabilitation > Health care programme or facility > Prison-based health service
MM-MO Crime and law > Justice system > Correctional system and facility > Prison
T Demographic characteristics > Prison Inmate (prisoner)

Repository Staff Only: item control page